New chemical entities (NCEs, also known as new molecular entities or NMEs) are compounds that emerge from the process of drug discovery.
The information is gathered from this pre-clinical testing, as well as information on CMC, and submitted to regulatory authorities (in the US, to the FDA), as an Investigational New Drug application or IND.